Quick Order Cart

Cat. No. ARG39950

DTX3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DTX3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with disruption of the human DTX3 gene in HEK293T cells. DTX3 encodes an E3 ubiquitin ligase that negatively regulates Notch signaling by targeting the Notch intracellular domain (NICD) for ubiquitin?proteasomal degradation. This loss?of?function model is designed for investigating Notch pathway regulation and ubiquitin ligase function in a widely used host background. Applications include cancer biology, drug target validation, and mechanistic studies using assays such as Western blot, RT?qPCR, and Notch reporter assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DTX3

    Gene Identifier

    NCBI Gene ID 196403

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DTX3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population featuring disruption of the human DTX3 gene. This product provides a heterogeneous loss-of-function model in the widely utilized HEK293T background, enabling systematic investigation of DTX3-dependent molecular mechanisms without the confounding effects of clonal selection. The polyclonal format captures the diversity of editing outcomes, offering a robust tool for functional genomics and pathway analysis.

The host cell line, HEK293T, is a derivative of human embryonic kidney epithelial cells that stably expresses the SV40 large T antigen. This modification permits high-level episomal amplification of transfected plasmids and enhances protein production, making these cells a preferred host for transient and stable expression studies, lentiviral/retroviral packaging, and a broad range of biochemical assays. Their epithelial origin and ease of manipulation render them particularly suitable for studying signaling networks relevant to development and disease.

DTX3 encodes an E3 ubiquitin ligase that negatively regulates the Notch signaling pathway. Upon engagement of Notch ligands such as DLL1 and JAG1, the NOTCH1 receptor undergoes proteolytic cleavage by ???secretase, releasing the Notch intracellular domain (NICD). NICD translocates to the nucleus, where it forms a transcriptional activation complex with RBPJ and MAML1, driving expression of target genes including HES1 and HEY1. DTX3 counteracts this activation by interacting with NICD and ubiquitin?conjugating enzymes, catalyzing ubiquitination and subsequent proteasomal degradation of NICD. It functions in concert with related ligases DTX1 and DTX2 to dampen Notch transcriptional output.

In the HEK293T context, loss of DTX3 is expected to perturb the normal attenuation of Notch signaling, thereby providing a defined cellular system to dissect the regulatory roles of this E3 ligase. The high transfection efficiency and robust growth characteristics of HEK293T cells facilitate detailed biochemical and functional analyses of DTX3?mediated ubiquitination, protein?interaction dynamics, and downstream gene expression changes. The polyclonal knockout population avoids artifacts associated with clonal isolates and captures a representative spectrum of editing events, making it a versatile tool for studying Notch?dependent processes.

This knockout model is ideally suited for a variety of research applications, including elucidation of Notch signaling regulation, investigation of ubiquitin ligase function, cancer biology studies where aberrant Notch activity plays a role, and drug target validation campaigns. Representative experimental approaches encompass Western blotting to assess NICD and target protein levels, RT?qPCR for HES1/HEY1 transcript quantification, Notch?responsive luciferase reporter assays, co?immunoprecipitation to probe DTX3?CNICD interactions, and ubiquitination assays to monitor NICD modification. For further information or to discuss custom applications, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)